AV-101 Stimulates the Formation of New Brain Cells in Nonclinical Studies - P&T Community

Submitted by Anonymous (not verified) on Thu, 01/31/2019 - 13:35

AV-101 Stimulates the Formation of New Brain Cells in Nonclinical Studies  P&T CommunitySOUTH SAN FRANCISCO, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company ...